Surgery remains the primary curative modality for most solid tumors. Its role extends beyond resection to staging, palliation, and enabling multimodal therapy.
| Type | Description | Examples |
|---|---|---|
| Diagnostic biopsy | Tissue confirmation | Core needle, excisional, endoscopic |
| Local excision | Tumor + narrow margin | Small breast lump, early melanoma, polyp |
| Wide local excision | Tumor + 1–2 cm margin | Breast conservation, soft tissue sarcoma |
| Radical/composite resection | Tumor + organ + nodes + adjacent structures | Whipple (pancreas), cystectomy (bladder), esophagectomy |
| Mohs micrographic | Layer-by-layer with frozen section margin control | High-risk BCC/SCC (face, hands) |
| Debulking / Cytoreduction | Reduce tumor burden (not curative alone) | Advanced ovarian, peritoneal metastases |
| Palliative | Relieve obstruction, bleeding, pain | Stenting, bypass, kyphoplasty |
| Prophylactic | Risk reduction in high-risk genetics | Mastectomy (BRCA), colectomy (FAP) |
| Reconstructive | Restore form/function after ablation | Breast recon (implant/flap), mandible fibula flap |
Surgery is not standalone; it is the cornerstone of a multimodal strategy tailored to tumor biology and patient factors.

www.alskrankheit.net © Gesundheitswissenschaften